Molecular floats with CHF 482m market cap
Swiss venture capital-backed biotech Molecular Partners listed on the Swiss Exchange yesterday with a market cap of CHF 482m.
More on DACH
Main Capital exits Onventis in SBO to Keensight
Exit from Main Fund V comes three years after the GP acquired the Germany-based procurement technology company
The Bolt-Ons Digest – 26 January 2023
Unquote’s selection of the latest add-ons, with ICG's Circet, Five Arrows' Mintec, Carlyle's Jagex, and more
German health minister’s 'locust sponsors' comments spook live healthcare deals
New entrants scared by remarks on limiting profits; existing investors expected to rush to complete bolt-ons
Ardian plans North American drive with tech, services deals on radar
French sponsor looks to more than double exposure to US and Canada when next flagship buyout fund launches
Latest News
Main Capital exits Onventis in SBO to Keensight
Exit from Main Fund V comes three years after the GP acquired the Germany-based procurement technology company
The Bolt-Ons Digest – 26 January 2023
Unquote’s selection of the latest add-ons, with ICG's Circet, Five Arrows' Mintec, Carlyle's Jagex, and more
Travers Smith names new head of PE and financial sponsors group
Lucie Cawood's appointment follows poaching of Ian Shawyer by Cleary Gottlieb earlier this month
German health minister’s 'locust sponsors' comments spook live healthcare deals
New entrants scared by remarks on limiting profits; existing investors expected to rush to complete bolt-ons